Skip to main content
KBS_Icon_questionmark link-ico

Three IoP academics ranked as world's leading scientific minds

Three academics from the Institute of Psychiatry at King’s College London are ranked among the world’s leading scientific minds in the field of Psychiatry and Psychology, according to the 2014 Thomson Reuters Highly Cited Researchers list.

The academics from the IoP include: 

  • Philip McGuire, Professor of Psychiatry & Cognitive Neuroscience
  • Sir Robin Murray, Professor of Psychiatric Research 
  • Allan Young, Professor in Mood Disorders

The Highly Cited Researchers list included three other King’s academics: Professor Christopher Matthew and Professor Timothy Spector in the field of Molecular Biology & Genetics, and Professor Stuart Neil in the field of Microbiology. 

A total of over 3,000 researchers worldwide earned the distinction, and the academics listed rank among the top 1% most cited for their subject field and year of publication, a mark of exceptional impact.

Professor Philip McGuire is Head of the IoP’s Department of Psychosis Studies. His research group is focused on investigating the neurocognitive basis of psychosis, particularly in the early phase of psychosis and in relation to specific symptoms. This research is facilitated through integration with clinical services for early intervention in psychosis (Oasis and LEO) and for people with hallucinations (Voices Clinic).

Professor Sir Robin Murray was among the first researchers to suggest that schizophrenia might in part be a neurodevelopmental disorder. He was involved in demonstrating the important role of environmental factors in the aetiology of schizophrenia including obstetric events and other early childhood hazards; the contribution of social adversity to the high rates of schizophrenia in African-Caribbean people living in the UK; and most recently that prolonged heavy abuse of cannabis can contribute to the onset of psychosis. 

Professor Allan Young’s research interests focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders. He heads the IoP’s Centre for Affective Disorders (CfAD), a centre of excellence for understanding the science related to mood and anxiety disorders, and developing new treatments, both psychological and pharmacological.

For further information about the Highly Cited list, please visit the website